Trial site
Keck Hospital of USC
- 15running trials
- 8closed trials
The trials here
What the 23 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers2 trials
- Colorectal cancer2 trials
- Depression2 trials
- High blood pressure2 trials
- Liver and biliary tract cancer2 trials
- Lung cancer2 trials
- Metastatic breast cancer2 trials
- Pulmonary arterial hypertension2 trials
- Acute myeloid leukaemia1 trial
- Cystic fibrosis1 trial
- Dermatomyositis and polymyositis (myositis)1 trial
- Diabetic foot ulcer1 trial
- and 8 more
- Phase
- Phase 37 trials
- Phase 25 trials
- Phase 12 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting8 trials
- Completed4 trials
- Not yet recruiting3 trials
- Recruiting3 trials
- Terminated3 trials
- Enrolling by invitation1 trial
- Withdrawn1 trial
- Lead sponsor
- Pfizer7 trials
- University of Southern California3 trials
- LivaNova2 trials
- United Therapeutics2 trials
- Abcuro, Inc.1 trial
- and 8 more
Running trials
Recruiting
Recruiting
Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation
Not yet recruiting
Recruiting
Recruiting
Evaluating a Lifestyle Intervention to Prevent Recurrence of Diabetic Foot Ulcers
Active, not recruiting
Active, not recruiting
Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Enrolling by invitation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Liver and biliary tract cancer2 recruiting
- Cystic fibrosis1 recruiting
- Depression1 recruiting
- Diabetic foot ulcer1 recruiting
- High blood pressure1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Completed
Withdrawn
Terminated
Completed
Transcranial Direct Current Stimulation for Post-stroke Motor Recovery
Terminated
Completed
Terminated
Completed
A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)
Site data: ClinicalTrials.govUpdated 17 Nov 2026